melanotan ii developed by which company (“Tan Jabs”): Why They're Not Worth The Risk MELANOTAN-2 – Research Peptide |
Description
2004;33:355-74.[PubMed Abstract] - 97.Gisbert JP, Garca-Buey L, Pajares JM, Moreno-Otero R
Based on Surveillance, Epidemiology, and End Results (SEER) data from CCA diagnoses between 2001 and 2017, the estimated 5-year mortality rate is 80.1% (Javle et al., 2022)
It also has therapeutic uses in the treatment of diabetes, specific cancers, and HIV
Gibbs Smith, Layton, Utah
35 RothmanS.OlneyJ
